Ticker Details
Apogee Therapeutics, Inc.
IPO Date:	July 14, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.45B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.17 | 2.71%
Avg Daily Range (30 D):	$1.70 | 2.27%
Avg Daily Range (90 D):	$1.55 | 2.13%

Institutional Daily Volume
Avg Daily Volume:	.49M
Avg Daily Volume (30 D):	.91M
Avg Daily Volume (90 D):	.82M

Trade Size
Avg Trade Size (Sh.):	55
Avg Trade Size (Sh.) (30 D):	57
Avg Trade Size (Sh.) (90 D):	56

Institutional Trades
Total Institutional Trades:	1,640
Avg Institutional Trade:	$3.08M
Avg Institutional Trade (30 D):	$4.44M
Avg Institutional Trade (90 D):	$4.21M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.95M
Avg Closing Trade (30 D):	$11.61M
Avg Closing Trade (90 D):	$9.86M
Avg Closing Volume:	98.74K

News

Mar 26, 2026 @ 3:33 PM Apogee CEO Sells 20,000 Shares as Stock Surges Nea... Source: Jonathan Ponciano

Mar 25, 2026 @ 1:53 AM Apogee Therapeutics, Inc. Announces Pricing of $35... Source: Na

Mar 22, 2026 @ 11:51 PM Apogee Therapeutics to Host Conference Call to Rep... Source: Na

Feb 25, 2026 @ 8:06 PM Apogee Therapeutics Stock Up 100% as Fund Lifts St... Source: Jonathan Ponciano

Jan 6, 2026 @ 11:00 AM Apogee Therapeutics Announces Positive Interim Res... Source: Na

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-4.22	$-1.03	$-4.22
Diluted EPS	$-4.22	$-1.03	$-4.22
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-255.84M	$-69.39M	$-255.84M
Operating Income / Loss	$-285.6M	$-78.06M	$-285.6M
Cost of Revenue
Net Cash Flow	$-10.53M	$23.64M	$-10.53M
PE Ratio

Splits
Jan 08, 2008	1:50